Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line
- PMID: 2516841
- PMCID: PMC5917935
- DOI: 10.1111/j.1349-7006.1989.tb01645.x
Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line
Abstract
In a papillary thyroid carcinoma cell line, TPC-1, we found transcripts hybridizing to ret proto-oncogene (proto-ret) cDNA probes. The transcripts hybridized to the probes encoding the kinase domain but not to those of the transmembrane and extracellular domains of proto-ret. The sizes of the main transcripts in TPC-1 were aberrant, being 2.0, 2.5, 4.0 and 5.0 kb. In the neuroblastoma cell lines, the transcripts were 3.9, 4.5, 6.0 and 7.0 kb, which have been proved to be generated by alternative splicing and polyadenylation from the non-altered proto-ret oncogene. All of the four transcripts in TPC-1 are about 2 kb smaller than the corresponding ones in the neuroblastoma. From the length of the transcripts, it is suspected that the transcripts in TPC-1 are a rearranged form of proto-ret. This is the first report describing the aberrant transcripts of proto-ret in a human tumor.
Similar articles
-
Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.Oncogene. 2001 Feb 15;20(7):885-92. doi: 10.1038/sj.onc.1204161. Oncogene. 2001. PMID: 11314023
-
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.Oncogene. 1994 Feb;9(2):509-16. Oncogene. 1994. PMID: 8290261
-
Proto-RET is rearranged in the new human papillary thyroid cancer cell line PTC-1113A.Cancer Genet Cytogenet. 1996 Jul 1;89(1):14-20. doi: 10.1016/0165-4608(95)00317-7. Cancer Genet Cytogenet. 1996. PMID: 8689603
-
The ret/PTC oncogene in papillary thyroid carcinoma.J Lab Clin Med. 1994 Mar;123(3):331-7. J Lab Clin Med. 1994. PMID: 8133143 Review. No abstract available.
-
Perspective on RET proto-oncogene and thyroid cancer.Cancer J. 2000 Mar-Apr;6(2):50-7. Cancer J. 2000. PMID: 11069217 Review.
Cited by
-
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer.NPJ Precis Oncol. 2024 Feb 20;8(1):39. doi: 10.1038/s41698-024-00536-7. NPJ Precis Oncol. 2024. PMID: 38378752 Free PMC article.
-
Acute exposure to diesel particulate matter promotes collective cell migration in thyroid cancer cells.Front Toxicol. 2023 Nov 30;5:1294760. doi: 10.3389/ftox.2023.1294760. eCollection 2023. Front Toxicol. 2023. PMID: 38098751 Free PMC article.
-
RET signaling pathway and RET inhibitors in human cancer.Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022. Front Oncol. 2022. PMID: 35957881 Free PMC article. Review.
-
FAM83B is involved in thyroid cancer cell differentiation and migration.Sci Rep. 2022 May 21;12(1):8608. doi: 10.1038/s41598-022-12553-2. Sci Rep. 2022. PMID: 35597845 Free PMC article.
-
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.J Exp Med. 2022 Jun 6;219(6):e20210390. doi: 10.1084/jem.20210390. Epub 2022 May 5. J Exp Med. 2022. PMID: 35510953 Free PMC article.
References
-
- ) Takahashi , M. , Buma , Y. , Iwamoto , T. , Inaguma , Y. , Ikeda , H. and Hiai , H.Cloning and expression of the ret proto‐oncogene encoding a tyrosine kinase with two potential transmembrane domains . Oncogene , 3 , 571 – 578 ( 1988. ). - PubMed
-
- ) Tahira , T. , Ishizaka , Y. , Itoh , F. , Sugimura , T. and Nagao , M.Characterization of ret proto‐oncogene inRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line . Oncogene , in press .
-
- ) Ishizaka , Y. , Ochiai , M. , Tahira , T. , Sugimura , T. and Nagao , M.Activation of the ret‐II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret‐II oncogene products differing in carboxy‐termini due to alternative splicing . Oncogene , 4 , 789 – 794 ( 1988. ). - PubMed
-
- ) Takahashi , M. , Ritz , J. and Cooper , G. M.Activation of a novel human transforming gene, ret, by DNA rearrangement . Cell , 42 , 581 – 588 ( 1985. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials